cyclophosphamide,bortezomib,daratumumab,dexamethasone,lenalidomide,melphalan
gsk,janssen,takeda
['lenalidomide', 'melphalan', 'leukemia', 'borte', 'muknine', 'dexamethasone', 'optimum,muknine', 'daratumumab', 'mmsm', 'myeloma xi', 'leusm', 'cyclophosphamide', 'bortezomib', ' lena', 'uk optimum']
this data from uk optimum/muknine trial--using extended intensified post-transplant consolidation in patients with ultra high-risk #myeloma &amp; primary plasma cell leukemia encouraging outcomes for this high-risk group of patients
#ash22 #mmsm #leusm 
Washington U. School of Medicine.
Assoc Director Hem/Onc Fellowship.
Myeloma, Amyloidosis, Leukemia, Lymphoma & BMT physician and researcher.
Tweets are my own.